Cargando…
Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis
Background: This study aimed to compare the diagnostic performance of carbohydrate-deficient transferrin (CDT) and gamma-glutamyltranspeptidase (γ-GTP) to assess the single and combined benefits of these biological markers for the detection of chronic excessive alcohol consumption in patients with a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307258/ https://www.ncbi.nlm.nih.gov/pubmed/34357155 http://dx.doi.org/10.3390/medicines8070039 |
_version_ | 1783728007304708096 |
---|---|
author | Shibamoto, Akihiko Namisaki, Tadashi Suzuki, Junya Kubo, Takahiro Iwai, Satoshi Tomooka, Fumimasa Takeda, Soichi Fujimoto, Yuki Enomoto, Masahide Murata, Koji Inoue, Takashi Ishida, Koji Ogawa, Hiroyuki Takagi, Hirotetsu Kaya, Daisuke Tsuji, Yuki Ozutsumi, Takahiro Fujinaga, Yukihisa Furukawa, Masanori Nishimura, Norihisa Sawada, Yasuhiko Kitagawa, Koh Sato, Shinya Takaya, Hiroaki Kaji, Kosuke Shimozato, Naotaka Kawaratani, Hideto Moriya, Kei Akahane, Takemi Mitoro, Akira Yoshiji, Hitoshi |
author_facet | Shibamoto, Akihiko Namisaki, Tadashi Suzuki, Junya Kubo, Takahiro Iwai, Satoshi Tomooka, Fumimasa Takeda, Soichi Fujimoto, Yuki Enomoto, Masahide Murata, Koji Inoue, Takashi Ishida, Koji Ogawa, Hiroyuki Takagi, Hirotetsu Kaya, Daisuke Tsuji, Yuki Ozutsumi, Takahiro Fujinaga, Yukihisa Furukawa, Masanori Nishimura, Norihisa Sawada, Yasuhiko Kitagawa, Koh Sato, Shinya Takaya, Hiroaki Kaji, Kosuke Shimozato, Naotaka Kawaratani, Hideto Moriya, Kei Akahane, Takemi Mitoro, Akira Yoshiji, Hitoshi |
author_sort | Shibamoto, Akihiko |
collection | PubMed |
description | Background: This study aimed to compare the diagnostic performance of carbohydrate-deficient transferrin (CDT) and gamma-glutamyltranspeptidase (γ-GTP) to assess the single and combined benefits of these biological markers for the detection of chronic excessive alcohol consumption in patients with alcoholic cirrhosis. Methods: Biological markers were determined in blood samples from patients with alcoholic cirrhosis (drinking group, n = 35; nondrinking group, n = 81). The prediction accuracy of %CDT alone, γ-GTP alone, and their combination for the detection of excessive alcohol consumption was determined in patients with alcoholic cirrhosis. Results: Serum total bilirubin, alanine aminotransferase, aspartate aminotransferase, γ-GTP, and alkaline phosphatase levels and %CDT were significantly higher and serum albumin levels were significantly lower in the drinking group than in the nondrinking group. The combination of %CDT and γ-GTP compared with %CDT or γ-GTP alone showed a higher prediction accuracy. The combination of %CDT and γ-GTP exhibited a higher specificity than γ-GTP alone. However, in terms of sensitivity, no significant difference was found between single or combined markers. Conclusions: The combination of %CDT and γ-GTP is considered a useful biomarker of chronic excessive alcohol consumption in patients with alcoholic cirrhosis. |
format | Online Article Text |
id | pubmed-8307258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83072582021-07-25 Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis Shibamoto, Akihiko Namisaki, Tadashi Suzuki, Junya Kubo, Takahiro Iwai, Satoshi Tomooka, Fumimasa Takeda, Soichi Fujimoto, Yuki Enomoto, Masahide Murata, Koji Inoue, Takashi Ishida, Koji Ogawa, Hiroyuki Takagi, Hirotetsu Kaya, Daisuke Tsuji, Yuki Ozutsumi, Takahiro Fujinaga, Yukihisa Furukawa, Masanori Nishimura, Norihisa Sawada, Yasuhiko Kitagawa, Koh Sato, Shinya Takaya, Hiroaki Kaji, Kosuke Shimozato, Naotaka Kawaratani, Hideto Moriya, Kei Akahane, Takemi Mitoro, Akira Yoshiji, Hitoshi Medicines (Basel) Article Background: This study aimed to compare the diagnostic performance of carbohydrate-deficient transferrin (CDT) and gamma-glutamyltranspeptidase (γ-GTP) to assess the single and combined benefits of these biological markers for the detection of chronic excessive alcohol consumption in patients with alcoholic cirrhosis. Methods: Biological markers were determined in blood samples from patients with alcoholic cirrhosis (drinking group, n = 35; nondrinking group, n = 81). The prediction accuracy of %CDT alone, γ-GTP alone, and their combination for the detection of excessive alcohol consumption was determined in patients with alcoholic cirrhosis. Results: Serum total bilirubin, alanine aminotransferase, aspartate aminotransferase, γ-GTP, and alkaline phosphatase levels and %CDT were significantly higher and serum albumin levels were significantly lower in the drinking group than in the nondrinking group. The combination of %CDT and γ-GTP compared with %CDT or γ-GTP alone showed a higher prediction accuracy. The combination of %CDT and γ-GTP exhibited a higher specificity than γ-GTP alone. However, in terms of sensitivity, no significant difference was found between single or combined markers. Conclusions: The combination of %CDT and γ-GTP is considered a useful biomarker of chronic excessive alcohol consumption in patients with alcoholic cirrhosis. MDPI 2021-07-19 /pmc/articles/PMC8307258/ /pubmed/34357155 http://dx.doi.org/10.3390/medicines8070039 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shibamoto, Akihiko Namisaki, Tadashi Suzuki, Junya Kubo, Takahiro Iwai, Satoshi Tomooka, Fumimasa Takeda, Soichi Fujimoto, Yuki Enomoto, Masahide Murata, Koji Inoue, Takashi Ishida, Koji Ogawa, Hiroyuki Takagi, Hirotetsu Kaya, Daisuke Tsuji, Yuki Ozutsumi, Takahiro Fujinaga, Yukihisa Furukawa, Masanori Nishimura, Norihisa Sawada, Yasuhiko Kitagawa, Koh Sato, Shinya Takaya, Hiroaki Kaji, Kosuke Shimozato, Naotaka Kawaratani, Hideto Moriya, Kei Akahane, Takemi Mitoro, Akira Yoshiji, Hitoshi Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis |
title | Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis |
title_full | Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis |
title_fullStr | Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis |
title_full_unstemmed | Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis |
title_short | Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis |
title_sort | clinical significance of gamma-glutamyltranspeptidase combined with carbohydrate-deficient transferrin for the assessment of excessive alcohol consumption in patients with alcoholic cirrhosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307258/ https://www.ncbi.nlm.nih.gov/pubmed/34357155 http://dx.doi.org/10.3390/medicines8070039 |
work_keys_str_mv | AT shibamotoakihiko clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT namisakitadashi clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT suzukijunya clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT kubotakahiro clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT iwaisatoshi clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT tomookafumimasa clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT takedasoichi clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT fujimotoyuki clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT enomotomasahide clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT muratakoji clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT inouetakashi clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT ishidakoji clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT ogawahiroyuki clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT takagihirotetsu clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT kayadaisuke clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT tsujiyuki clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT ozutsumitakahiro clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT fujinagayukihisa clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT furukawamasanori clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT nishimuranorihisa clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT sawadayasuhiko clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT kitagawakoh clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT satoshinya clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT takayahiroaki clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT kajikosuke clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT shimozatonaotaka clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT kawaratanihideto clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT moriyakei clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT akahanetakemi clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT mitoroakira clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis AT yoshijihitoshi clinicalsignificanceofgammaglutamyltranspeptidasecombinedwithcarbohydratedeficienttransferrinfortheassessmentofexcessivealcoholconsumptioninpatientswithalcoholiccirrhosis |